• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.黑色素瘤细胞表达 ICOSL 配体以促进 T 调节细胞的激活和扩增。
Cancer Res. 2010 Dec 1;70(23):9581-90. doi: 10.1158/0008-5472.CAN-10-1379. Epub 2010 Nov 23.
2
Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.急性髓系白血病细胞表达 ICOSL 配体促进调节性 T 细胞的扩增。
Front Immunol. 2018 Sep 26;9:2227. doi: 10.3389/fimmu.2018.02227. eCollection 2018.
3
Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.尼古丁刺激 α7 烟碱型乙酰胆碱受体可增加体外培养的小鼠天然存在的 CD4+CD25+调节性 T 细胞的抑制能力。
J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15.
4
Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.黑色素瘤细胞中 Foxp3 的表达可能是对免疫破坏产生抵抗的机制之一。
Cancer Immunol Immunother. 2011 Aug;60(8):1109-18. doi: 10.1007/s00262-011-1025-3. Epub 2011 May 6.
5
ICOS Foxp3 TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.胃癌中ICOS Foxp3肿瘤浸润淋巴细胞是预后标志物及与幽门螺杆菌相关的效应调节性T细胞。
Int J Cancer. 2017 Feb 1;140(3):686-695. doi: 10.1002/ijc.30475. Epub 2016 Oct 27.
6
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.人黑色素瘤浸润性CD4+CD25高表达Foxp3+调节性T细胞上诱导共刺激分子(ICOS)的表达:对肿瘤介导的免疫抑制的影响
J Immunol. 2008 Mar 1;180(5):2967-80. doi: 10.4049/jimmunol.180.5.2967.
7
INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.INFα-2b对携带黑色素瘤异种移植瘤的C57BL/6 J小鼠肿瘤微环境中CD4(+)CD25(+)FOXP3(+)调节性T细胞的抑制作用。
BMC Cancer. 2016 Jul 7;16:397. doi: 10.1186/s12885-016-2473-0.
8
Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.同种异体诱导的人FOXP3(+)IFN-γ(+)T细胞表现出选择性抑制能力。
Eur J Immunol. 2009 Oct;39(10):2703-15. doi: 10.1002/eji.200839097.
9
IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.IDO 表达的成纤维细胞促进抗原特异性调节性 T 细胞的扩增。
Immunobiology. 2014 Jan;219(1):17-24. doi: 10.1016/j.imbio.2013.06.008. Epub 2013 Jun 25.
10
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.分泌白细胞介素-10和转化生长因子-β1的CD4+CD25高表达Foxp3+ T细胞的一个独特亚群介导肿瘤微环境中的抑制作用。
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54. doi: 10.1158/1078-0432.CCR-07-0472.

引用本文的文献

1
The costimulatory molecule ICOS limits memory-like properties and function of exhausted PD-1CD8 T cells.共刺激分子ICOS限制耗竭性PD-1⁺CD8⁺ T细胞的记忆样特性和功能。
Immunity. 2025 Jul 1. doi: 10.1016/j.immuni.2025.06.001.
2
Computational Design of a Bicyclic Peptide Inhibitor Targeting the ICOS/ICOS-L Protein-Protein Interaction.靶向ICOS/ICOS-L蛋白-蛋白相互作用的双环肽抑制剂的计算设计
Chem Biol Drug Des. 2025 May;105(5):e70117. doi: 10.1111/cbdd.70117.
3
ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesis.ICOS+CD4+ T细胞表明对抗PD-1治疗诱导的肺部病变高度敏感。
JCI Insight. 2025 Apr 8;10(10). doi: 10.1172/jci.insight.186483. eCollection 2025 May 22.
4
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy.白细胞介素-2受体(IL-2R)激动剂在癌症免疫治疗中的现状与未来前景
Oncoimmunology. 2025 Dec;14(1):2452654. doi: 10.1080/2162402X.2025.2452654. Epub 2025 Jan 15.
5
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.SWI/SNF 复合物改变的晚期肿瘤中肿瘤浸润淋巴细胞的临床方案 II 期研究:TILTS 研究。
Future Oncol. 2024;20(32):2437-2445. doi: 10.1080/14796694.2024.2385287. Epub 2024 Aug 12.
6
Correlation between Tregs and ICOS-induced M2 macrophages polarization in colorectal cancer progression.调节性T细胞与诱导性共刺激分子诱导的M2巨噬细胞极化在结直肠癌进展中的相关性
Front Oncol. 2024 Jul 22;14:1373820. doi: 10.3389/fonc.2024.1373820. eCollection 2024.
7
Differential Immune Checkpoint Protein Expression in HNSCC: The Role of HGF/MET Signaling.头颈部鳞状细胞癌中免疫检查点蛋白的差异表达:HGF/MET 信号的作用。
Int J Mol Sci. 2024 Jul 4;25(13):7334. doi: 10.3390/ijms25137334.
8
T-Cell Engagers-The Structure and Functional Principle and Application in Hematological Malignancies.T细胞衔接器——结构、功能原理及在血液系统恶性肿瘤中的应用
Cancers (Basel). 2024 Apr 20;16(8):1580. doi: 10.3390/cancers16081580.
9
Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules.间充质基质/干细胞与免疫检查点相关分子的治疗及免疫调节潜力
Biomark Res. 2024 Mar 21;12(1):35. doi: 10.1186/s40364-024-00580-2.
10
Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T-cell costimulator as a crucial immune checkpoint molecule.结直肠癌的转录谱和免疫浸润揭示了诱导型 T 细胞共刺激因子作为关键免疫检查点分子的重要意义。
Cancer Med. 2024 Mar;13(6):e7097. doi: 10.1002/cam4.7097.

本文引用的文献

1
Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints.抗 CD3 治疗允许调节性 T 细胞克服 T 细胞受体特异性外周龛位限制。
J Exp Med. 2010 Aug 30;207(9):1879-89. doi: 10.1084/jem.20100205. Epub 2010 Aug 2.
2
T helper 17 cells promote cytotoxic T cell activation in tumor immunity.辅助性T细胞17在肿瘤免疫中促进细胞毒性T细胞活化。
Immunity. 2009 Nov 20;31(5):787-98. doi: 10.1016/j.immuni.2009.09.014. Epub 2009 Oct 29.
3
[Expression of ICOSL on human coronary artery endothelial cells and its being interferentialed by ox-LDL].[人冠状动脉内皮细胞上ICOSL的表达及其受氧化型低密度脂蛋白的干扰]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Sep;25(9):819-21.
4
Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes.新诊断1型糖尿病患儿调节性T细胞中ICOS、GITR和CTLA-4在mRNA水平的表达降低。
Acta Biochim Pol. 2009;56(2):361-70. Epub 2009 Jun 20.
5
Human T regulatory cell therapy: take a billion or so and call me in the morning.人类调节性T细胞疗法:先准备大约十亿个,明天早上再联系我。
Immunity. 2009 May;30(5):656-65. doi: 10.1016/j.immuni.2009.04.006.
6
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.表达FoxP3转录因子的人CD4+ T细胞的功能划分与分化动力学
Immunity. 2009 Jun 19;30(6):899-911. doi: 10.1016/j.immuni.2009.03.019. Epub 2009 May 21.
7
Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood.人血液中具有调节功能的白细胞介素-10/γ干扰素产生效应样T细胞的鉴定与表征
J Exp Med. 2009 May 11;206(5):1009-17. doi: 10.1084/jem.20082238. Epub 2009 May 4.
8
Regulatory T cells in the control of host-microorganism interactions (*).调节性T细胞在宿主-微生物相互作用的调控中(*)。
Annu Rev Immunol. 2009;27:551-89. doi: 10.1146/annurev.immunol.021908.132723.
9
FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions.FOXP3表达准确地定义了在转移性黑色素瘤病灶中选择性聚集的肿瘤内调节性T细胞群体。
Blood. 2008 Dec 15;112(13):4953-60. doi: 10.1182/blood-2008-06-163048. Epub 2008 Sep 26.
10
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.调节性和炎性T细胞程序的分子拮抗作用与可塑性
Immunity. 2008 Jul 18;29(1):44-56. doi: 10.1016/j.immuni.2008.05.007. Epub 2008 Jun 26.

黑色素瘤细胞表达 ICOSL 配体以促进 T 调节细胞的激活和扩增。

Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.

机构信息

Department of Immunology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA.

出版信息

Cancer Res. 2010 Dec 1;70(23):9581-90. doi: 10.1158/0008-5472.CAN-10-1379. Epub 2010 Nov 23.

DOI:10.1158/0008-5472.CAN-10-1379
PMID:21098714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3058814/
Abstract

CD4(+)CD25(+)Foxp3(+) T-regulatory cells (Tregs) accumulate in tumors; however, little is known about how the tumor environment influences this process. Here we show that human melanomas express inducible T-cell costimulator ligand (ICOS-L/B7H) that can provide costimulation through ICOS for the expansion of activated Tregs maintaining high Foxp3 and CD25 expression as well as a suppressive function. Thus, ICOS-L expression by melanoma tumor cells may directly drive Treg activation and expansion in the tumor microenvironment as another mechanism of immune evasion.

摘要

CD4(+)CD25(+)Foxp3(+) T 调节细胞(Tregs)在肿瘤中积累;然而,人们对肿瘤环境如何影响这一过程知之甚少。在这里,我们表明人类黑色素瘤表达可诱导 T 细胞共刺激配体(ICOS-L/B7H),可通过 ICOS 为激活的 Tregs 的扩增提供共刺激,从而维持高 Foxp3 和 CD25 的表达以及抑制功能。因此,黑色素瘤肿瘤细胞表达的 ICOS-L 可能通过另一种免疫逃逸机制直接驱动肿瘤微环境中 Treg 的激活和扩增。